FOLLOWING a recent perusal of the papers by Codman and Kolodony on the work of the American Registry of Bone Sarcoma, I suggested to your Secretary at the time that a summary of the conclusions derived from them would be of use, and perhaps provoke discussion. The tendency of these papers is towards simplification of our classification of bone tumours, our views on their pathology, and our criteria of diagnosis. True, the conclusions arrived at are provisional. There are many varieties of tumour which will not fit into any presenit scheme of classification. There have also been published other important papers by American writers since the two I have mentioned. At the International Cancer Conference in July, 1928, one session, devoted to the subject of the classification of bone sarcoma, was opened by Professor Ewing. His opinions were those of the pathologist, and the many subdivisions which he introduced are, I consider, more of pathological than of clinical interest. As surgeons we are concerned more with divisions corresponding to clinical types, which help us in prognosis and treatment. From this standpoint Kolodony's summary, though it is two years old, gives us a very definite basis for our own study.
FOLLOWING a recent perusal of the papers by Codman and Kolodony on the work of the American Registry of Bone Sarcoma, I suggested to your Secretary at the time that a summary of the conclusions derived from them would be of use, and perhaps provoke discussion. The tendency of these papers is towards simplification of our classification of bone tumours, our views on their pathology, and our criteria of diagnosis. True, the conclusions arrived at are provisional. There are many varieties of tumour which will not fit into any presenit scheme of classification. There have also been published other important papers by American writers since the two I have mentioned. At the International Cancer Conference in July, 1928, one session, devoted to the subject of the classification of bone sarcoma, was opened by Professor Ewing. His opinions were those of the pathologist, and the many subdivisions which he introduced are, I consider, more of pathological than of clinical interest. As surgeons we are concerned more with divisions corresponding to clinical types, which help us in prognosis and treatment. From this standpoint Kolodony's summary, though it is two years old, gives us a very definite basis for our own study.
In 1920, the family of a patient under the care of Dr. A. E. Codman, of Boston, gave a sum of money for the foundation of a Registry of Bone Sarcoma. This Registry has done work of incalculable value. To it have been sent complete records of cas6s of bone sarcoma from all over America, which included a careful clinical history, photographs of the patient, radiograms at all stages, accessory laboratory tests, portions of the tumour removed for section, the gross specimen if amputation was performed, and the post-mortem findings in fatal cases. This material has been carefully analysed by a team of experts.
The following provisional classification of bone tumours was adopted by the Registry at its inception: (1) Metastatic Tumours, primary This classification does not include all bone tumours, and it comprises several conditions which do not belong to the category. It is merely a subdivision of skeletal lesions, the general characters of which might cause them to be sent to the Registry for investigation. To provide a working classification for teaching and text-book purposes, I suggest that we should add to this list the common nonmalignant tumours of bone, and omit those which are underlined-the metastatic tumours and inflammatory conditions because they are not growths of bone, and the angiomata because of their great rarity and their origin from vascular and not osseous tissues. We get thus the following list of bone tumours, innocent and malignant: Following Bland-Sutton, I keep the term "exostoses " for bony outgrowths due to irritation or to ossification in tendon, and reserve osteomata" for innocent new growths of bone. Cancellous osteomata are outgrowths due to misplacements of JUNE-ORTH. 1 epiphyseal cartilage, occurring in typical situations during the growth period. Innocent osteogenic tumours-much rarer-arise independently of normal bone growth from an aberrant activity of osteogenic cells (fig. 1 ). The single and multiple chondromata fQrm two distinct groups from their site, age-incidence, and clinical characters.
Giant-cell Tumours.-The term "giant-cell tumour" is purely descriptive, and prejudges neither the nature of the tumour, nor the origin of its most characteristic elements. It is preferable to "myeloma," because the tumour does not arise from marrow elements; to "innocent central tumours," for distant metastases do in rare instances occur; and it is preferable to "myeloid sarcoma," which is wrong on both counts. The tumour tissue comprises two elements, the stroma and the giant cells. The stroma consists of thin-walled blood spaces in a loose network of spindle-shaped or polygonal cells of uniform size, with large nuclei; it may be very vascular, myxomatous, fibrous, or may contain lipoids. The colour, when fresh, varies from the red-currant jelly of the usual specimens to a bright yellow in the last-named variety. The giant cells are loosely embedded in the stroma; they differ from tumour giant cells seen in any rapidly growing tumour, where the nuclei are of various sizes and often incompletely separated, also from foreign body giant cells, where the nuclei are grouped round the periphery; they have nuclei of equal size, separate, and distributed through the central portion of the cell. They thus resemble, and are considered by Stewart to be derived from, the osteoclasts.
The tumour, during its progress, destroys bone, while the periosteum lays down a shell of new bone enclosing the tumour. Strands of thickened bone remain in the wvalls, giving a "soap-bubble" appearance in radiograms. The bone shell may be Q2 1060 finally destroyed, but the fibrous periosteum continues to enclose the tumour tissue till very l-ate. The tumour is separated by a layer of condensed bone from the medullary cavity; it invades the extremity of the bone and approaches the articular cartilage, but, until late, is separated from it by a certain amount of cancellous bone.
Giant-cell tumours are less common than sarcomata in the proportion of 1 to 2. Tbe majority occur between the ages of 16 and 25-later than the common age for osteogenic sarcoma. They are nearly always solitary; 56% occur in the lower extremity, 23% in the upper, 21% in the trunk. In the lower extremity 57% are in the femur, nearly all in the lower end, and 36% in the tibia, three-fourths in the upper end; 9% are in the jaws, equally divided between the upper and lower, 8% per cent. in the spine. They are more common than sarcoma in the small bones of the extremities. In fact, 47% of all giant-cell tumours are in the neighbourhood of the knee-joint.
The clinical aspect of these growths is familiar. The general health remains& good. Pain is frequent, but rarely severe; there may be fluid in the neighbouring joint. The patient's attention is usually attracted by swelling. Upon examination the detection of a bulky spherical mass near the end of a long bone and sharply demarcated from the neighbouring shaft is almost diagnostic; there is no tenderness, egg-shell crackling may be felt and a bruit is sometimes heard.
Par-osteal Sarcomas.-Par-osteal sarcomas are rare; they arise from the fibrous. layer of the periosteum, that is, from non-specific cells, and therefore do not produce bone. They do not differ from the sarcomas of fasciae, and their connexion with bone is fortuitous. Histologically, they are fibro-sarcomata; the cells are spindle-shaped and intercellular substance abundant: some are softer and more cellular. They remain encapsuled for a long time, pushing aside neighbouring structures rather than infiltrating their tissues. The investing capsule is not formed, as in true bone sarcomas, by periosteum. They may cause, by pressure, superficial erosion of the bone from which they arise, or may give rise to localized hypersrophy, but such changes are slight. When growing in an interosseous space they may bend the shaft of the weaker bone.
Osteogenic Sarcomas.-The term "osteogenic sarcoma " includes all primary bone sarcomas not in the other groups, mainly those usually known as periosteal bone sarcomas. They constitute by far the commonest malignant tumour of bone. The word implies a sarcoma derived from bone cells, and not a bone-forming sarcoma. It is a tumour derived from ancestors of cells which, in their fully differentiated state, are osteoblasts; they are found in all stages of differentiation as spindle cells, cartilage .cells, or true bone cells, but never as round cells. Bone formation is merely a potentiality and need not occur. If the tumour is slow-growing and well differentiated, the cells may lay down bone; if it is undifferentiated and growing fast, bone destruction predominates. The osteoblastic type is common in children, the osteolytic in adults.
Any subdivision of the group of osteogenic sarcomas, as that outlined by Ewing, is very difficult, and does not appear to be of real clinical value. A tabulation based upon the microscopic characters of the tumour tissue is questionable, for the majority of these tumours, if they are studied throughout their extent, show in different parts, every type of mesoblastic tissue. The position of the tumour, whether periosteal or endosteal, cannot be decided upon clinical evidence. Nor is X-ray evidence any more reliable: for the better the radiogram, the more likely is it to show involvement of all parts of the bone. A fan-like arrangement of spicules does not mean that the sarcoma is of periosteal origin, for this is seen somewhere in nearly all osteogenic sarcomas. It merely means that periosteum is involved, and the appearance is seen, as shown by Julian Taylor, in purely inflammatory conditions. A study of the pathological anatomy demonstrates the uncertainty of any such subdivision, for no early and localized sarcoma, limited to the periosteal or endosteal tissues, is ever encountered; it is impossible to tell by inspection of the specimen where the sarcoma began or where invasion stops, and histological study always shows that this is beyond the limits of visible tumour tissue. The preponderating site of the tumour in the bone has no bearing upon the clinical course of the neoplasm, or upon its ultimate prognosis.
Osteogenic sarcoma advances along the paths of least resistance. In the medulla it spreads freely and soon fills the whole cavity. Compact bone is permeated rather than absorbed or displaced. The shaft tends to persist as a framework in the middle of the tumour tissue, retaining its original outline and position even when thinned or fragmented. The periosteum is lifted off, and in the process lays down bone, on the surface, as radiating spicules, at the periphery as a shelf, the "reactive triangle of Codman" (fig. 2 ). The tumour, limited for a time by the periosteum, assumes a spindle shape; at the epiphyseal line it is temporarily arrested, and expanding, still under the periosteum, becomes -club-shaped. Once the periosteum is transgressed these sarcomas spread rapidly, and lose all arrangement. They aie checked, in addition to the periosteum, by skin, which is stretched bult never perforated, and by cartilage, both epiphyseal and articular. They are therefore more likely to invade a joint in the adult than in the child. Surgical exploration, by breaching the periosteum, leads to a rapid extension of the growth locally.
Distant metastases occur early, and may be found anywhere, but are far commonest in the lungs. Here they are usually subpleural in position, and tend to grow slowly: they often show well-developed bone with Haversian systems.
Osteogenic sarcomas are the commonest malignant mesoblastic tumours, the next most frequent being lympho-sa'rcomas. Nevertheless they are sufficiently rare, cne 3£ 1062 in 100,000 in America, 1 in 75,000 in Britain. They are commoner in males in the proportion of 4 to 3. No age is immune, but the great majority arise in the second decade: they are rare under 10, and very rare over 50. No authentic instance of a congenital osteogenic sarcoma has reached the Registry.
The most common site is the metaphysis of a long bone; 72% of all cases affect the lower limb, and 82% of these occur round the knee-that is 59% of all osteogenic sarcomas arise near the knee-joint. The bones are involved in the following order of frequency. The femur, tibia, humerus, pelvis (especially the ilium), fibula, shoulder-girdle, hands and feet (excluding the phalanges), ribs, skull, jaws, vertebrae. The femur is attacked in 52% of all cases, four times out of five at its lower end; the tibia in 20%, nine times out of ten at its upper end and usually on its inner side; the humerus in 9%, commonly in the upper third or at the insertion of the deltoid. The lower ends of the humerus and of the fibula are very rarely involved. No true instance of osteogenic sarcoma occurring in the lower end of the tibia, the ulna or the radius, or in the patella has been reported to the Registry, a fact of considerable importance when the frequency of giant-cell tumour in these sites is
remembered. Osteogenic sarcomas are single tumours; multiplicity is only seen when malignant changes have occurred in some generalized lesion of the skeleton, such as Paget's disease or chondromata. On the other hand, involvement of more than one bone is the rule, in Ewing's tumour and in myeloma.
The clinical history of a case of bone sarcoma is familiar to orthopmdic surgeons, I shall, therefore, enumerate only the most important points under diagnosis. Pain is the earliest and most constant symptom of a true bone sarcoma; it is severe and unremitting, except in the early stages, and it prevents sleep. The pain of osteogenic sarcoma is due to stretching of the periosteum; it is, therefore, not related to the onset of the disease, but to the onset of the lump. Because of the severity of the pain, which prevents use of the limb, pathological fractures are uncommon; they are usually transverse, and not infrequently unite.
Ewing's Tumour.-The identification of a new malignant tumour of bone hitherto unrecognized in clinical surgery, yet possessing specific clinical, pathological, and histological characters, is one of the most striking advances that have been made JUNE-ORTH.. 2 * possible by the abundant material at the disposal of the Registry. Ewing himself calls the tumour a diffuse endothelioma.
The tumour tissue consists of small polyhedral cells of uniform size, with scant cytoplasm and an oval or elongated nucleus. A characteristic feature is the complete absence of intercellular substance. The cells often imitate a syncytium; sometimes they are arranged round blood-vessels (fig. 3 ).
The tumour tissue is soft and greyish white, having, on a cursory examination, a resemblance to pus. In the early stages it occupies a cavity in the bone like a focus of osteo-myelitis; later it spreads more widely. Necrosis of bone may occur, but extreme vascularity such as is common in osteogenic sarcoma is never seen.
The sites favoured by Ewing's sarcoma are the small bones of the extremities and the skull. In the long bones it attacks the shaft and not the metaphysis. It involves the shaft widely, and often seems to begin simultaneously in numerous areas of the affected portion of the bone. The tumour cells spread rapidly along the bone, pushing aside the lamellh. At an early stage the X-ray appearance closely simulates that of osteomyelitis. The cells penetrate along the Haversian spaces. to the surface. The periosteum undergoes a protective reaction and lays down a shell of new bone; as the tumour advances, successive concentric shells are thus laid down, often called "onion layers" ( fig. 4A and 4B ).
Metastases are carried both by the bloodand the lymph-streams. The lymphatic mode of spread is much more common than in osteogenic sarcoma, and the regional glands are frequently affocted. Unlike osteogenic sarcoma, Ewing's tumour commonly gives rise to mbeastases in other bones, especially those of the skull. The lungs, the skull, and the glands, are the most frequent sites; other organs are rarely affected. These metastases have the microscopic structures of the primary growth, and bone formation does not occur.
Cases of Ewing's tumour constitute about 7-5 % of all, those diagnosed as bone sarcome.. It is commoner in males, in the proportion of 3 to 1. The maximum incidence is between the ages of 5 and 15 (the same age-incidence as that of osteo-myelitis). The commonest site of this tumour is in the cancellous bones: the long bones are also attacked, in the following order of frequency: the tibia, fibula, humierus, ulna, and femur. When the spine or the foot are affected, foci usually appear simultaneously in several adjacent vertebra or tarsal bones: such are probably true multiple tumours, and not metastases. In the long bones the disease usually involves the shaft for at least half its length; it may spread to the end of the bone, but, unlike osteogenic sarcoma, does not reach the articular cartilage.
The clinical history is characteristic and extremely important, because of its resemblance to that of subacute or chronic osteo-myelitis. Pain is a constant feature. It is more often intermittent than in osteogenic sarcoma, with intervals lasting at first several months, but becoming progressively shorter, till finally pain is continuous. Pyrexia is very common, and accompanies the attacks of pain. The attacks of pain and fever may recur for a year before any tumour is noticed. The swelling on the bone appears suddenly, often accompanied by local heat and hyperwmia; it may subside at first, but ultimately increases rapidly. Pathological fracture is rare, and joint involvement uinknown. The skin remains free, but after surgical exploration the tumour fungates. The blood picture is inconstant; in the early stages there may be a leucocytosis, and in the terminal ones an anaemia is usual.
Myeloma.-Myelomatosis is a very rare condition, seldom recognized till it is far advanced.
The appearance, upon microscopic section of the tissue removed from foci in the bones, is that of round cells loosely packed, with no definite arrangement. The common type of cell resembles the plasma cell, and is mononuclear with an opaque basophilic cytoplasm. There is no intercellular substance. Myelomatosis is most prevalent at the midpoint of the long bones, especially the humerus and the femur, and the flat bones, the sternum, ribs, skull, and vertebre. (Fig. 5 .) It occurs in the form of multiple nodules varying from the size of a pea to that of an orange. The cells spread rapidly along the medulla, replacing normal tissues; they also ext,end transversely, producing a destruction more circumscribed and rapid than that seen in Ewing's tumour. Bending and fracture of the affected bone are common.
Males from 40 to 60 years of age are usually affected. The clinical features of the disease are obscure, for, apart from a general loss of health, there are usually no symptoms till the appearance of a pathological fracture, or the collapse of n vertebra with sudden onset of paraplegia, directs attention to the lesion in the skeleton. Diffuse involvement of all the bones is found in the later stages, and leads to death from emaciation and anamia, but metastases outside the osseous system are the exception. They have been found in the liver, spleen, kidneys, glands and skin.
Diagnosis. The question of diagnosis centres mainly upon the diagnosis of osteogenic sarcoma, the commonest and the most malignant of bone tumours. A correct diagnosis is of incalculable importance, not only because in the discovery of bone sarcomas at the earliest possible stage lies the only hope of occasional cure, but because the differentiation between innocence and malignancy in a tumour of doubtful nature will dictate the line of treatment to be adopted-amputation in one case, more conservative measures in the other-and the prognosis that must be offered to the patient. In making his decision the surgeon has to rely entirely upon his clinical judgment, and can expect little help from his colleagues. Radiograms rarely give definite assistance except in those advanced cases in which the diagnosis is indisputable on clinical grounds. Exploration of a doubtful swelling is never permissible, for in malignant cases it liberates the tumour from its restraining envelope and leads to rapid local extension, and, in addition, sets up metastases if these are not already present; in any case the opinion that can be formed from microscopic investigation is usually inconclusive. It is therefore imperative that those who may meet such cases should be familiar with the leading characters of the clinical picture they present. Codman has laid down twenty-five criteria for establishing the diagnosis of osteogenic sarcoma. These fall into five groups: five are based upon history, five on clinical examination, five on X-ray examination, five on microscopic investigation, and five on general considerations. For the reasons just stated, the first two groups of clinical criteria transcend the others in importance.
The points in the history are as follows:
(1) Onset.-Pain is early and constant, and unless it precedes other symptoms we may suspect that the case is not one of osteogenic sarcoma.
(2) Duration.-The pain at first is bearable, and then steadily increases. If the patient presents himself less than a month or more than a year after the first onset of the pain, the case is probably not one of osteogenic sarcoma. In benign osteogenic growths a history of several years is common.
(3) The General Condition.--:Bone sarcoma appears to be a disease of the healthy.
If, therefore, a patient is in bad health at the time of onset, the probabilities are in favour of a diagnosis other than that of sarcoma.
(4) Age.-No instances of osteogenic sarcoma arising in patients over the age of 50, with the exception of cases supervening on Paget's disease, have been reported to the Registry.
(5) Rapidity of Growth.-Benign osteogenic tumours (this does not include giant-cell tumours) grow slowly, the change in size being noticeable only from year to year. Inflammatory conditions change from day to day or from week to week. Osteogenic sarcomas show a steady enlargement, which is nearly always noticeable after a month.
The following five points in the clinical e'xamination of the case are nearly always found.
(1) Situation.-One-half of all bone sarcomas occur in the femur, one-quarter in the tibia, one-eighth in the remaining long bones. Of all situations, the neighbourhood of the knee-joint is the most common. The phalanges of the toes and fingers, the carpal bones and most of the small tarsal bones appear to be exempt. Osteogenic sarcoma is rare in the shaft of a long bone, but this is the common site for Ewing's tumour, myeloma, and metastases from carcinoma.
(2) Size and Shape.-No bone sarcoma of small size or pedunculated shape has been reported to the Registry. Osteogenic sarcomata are usually extensive when first noticed, and surround the bone completely or in part.
(3) Immobility of Soft Parts.-If the soft parts over a bony tumour are freely movable, the sign may be taken to exclude the possibility of bone sarcoma. The reverse is, of course, not true, for inflammatory conditions cause a greater degree of fixation than sarcomata.
(4) Condition of the Neighbouring Joint.-Sarcoma rarely invades a neighbouring joint till late in the course of the disease, except when it follows trauma. Limitation of movement is not due to spasm, as in the case of inflammatory lesions, but is proportionate to the degree of involvement of the muscles. Therefore a case in which FIG. 6.-Osteogenic sarcoma of the femuiv in a boy aged 5. Radiograms before and three weeks after therapeutic radiation. movement in a neighbouring joint is considerably limited at an early stage is probably not one of bone sarcoma.
(5) Absence of Inflammatory Signs.-Fever, leucocytosis, and local tenderness and redness are rare in osteogenic sarcoma, but not in Ewing's tumour.
To these cardinal diagnostic points should be added one other, the test of therapeutic radiation, which should be applied in every doubtful case. Radiationand by this is meant deep X-ray therapy, which appears superior to radium-evokes a rapid response in cellular osteogenic sarcoma; pain ceases, growth is retarded, the shadow of the tumour in radiograms becomes denser and its outline more definite (fig. 6 ). The response in ossifying tumours is less marked, but the relief of pain is striking. Ewing's tumour and myeloma respond more rapidly than bone sarcoma.
The difficulty of basing an opinion in early cases upon the radiographic appearances has already been mentioned. It must be insisted that X-ray proof of innocence is of no value when opposed to clinical signs suggesting malignancy. Characteristic appearances are, in the osteoblastic growths, the presence of sun-ray spicules, and of Codman's shelf at the periphery of the tumour and in the osteolytic growths, the shadow of the old shaft, blotched, but of its former shape, traversing a fusiform swelling. The condition is differentiated from osteogenic sarcoma by its situation in the centre of a long bone, by the radiographic appearances of widening of the shaft and deposition of concentric layers of new bone under the periosteum, by the discovery of similar changes in other bones, by a history of intermittent symptoms, and by the more rapid response to therapeutic radiation (fig. 7) . It is distinguished from osteomyelitis by a careful consideration of the history and X-ray appearances, and, again, by the trial of X-ray therapy, which will not affect the course of an infective lesion.
Diagnosis of
Diagnosis of Myeloma.-Myeloma can be diagnosed with certainty by X-ray examination of the whole skeleton, including the skull (fig. 8 ). The presence of multiile bone involvement, with no lung metastases, is typical. Not only are many bones involved, but in each bone multiple areas of circumscribed loss of density without any new bone formation may be seen, giving a wavy outline to the inner margin of the cortical layers.
Diagnosis of Giant-cell Tumour.-These tumours are usually diagnosed correctly upon the history and clinical examination alone; their appearance in radiograms is in most cases unmistakable. They present a bulky, spherical outline, divided by trabeculh so that the whole has a multicystic, or " soap-bubble " appearance.
There is an abrupt transition from the normal shaft to the thin shell of the tumour. This shell is continued as a narrow line of condensed bone between the tumour and the medullary cavity and, except in late cases, between the tumour and the articular cartilage. Beyond the tumour the cortex is normal, and a periosteal shelf is *ever seen.
Fibrocystic disease, which may resemble giant-cell tumour, expands the bone to a much less degree; moreover, the expansion is less abrupt, so that the cortex thins gradually, and does not give the impression of having been blown out under high tension. Cysts generally involve the shaft near the end of the bone, and not the articular end itself.
Treatment and Prognosis.-The outlook in a case of true osteogenic sarcoma treated by any means is so dark, that it is very nearly true to say that ultimate recovery throws considerable doubt upon the correctness of the diagnosis.
Proceedings of the Royal Society of Mdedicine
No case of undoubted osteogenic sarcoma treated by Coley's fluid alohe has recovpred, though in some cases in which this treatment was followed by amputation, the patients survived five years.
Radiation is of definite value, but only in the hands of an expert using the most efficient apparatus. Insufficient radiation appears to stimulate the growth; excessive radiation damages normal structures, and leads, in the bone, to sclerosis, fracture with no subsequent repair, ankylosis of joints, and intractable pain. Correct dosage arrests the growth and promotes the sclerosis, but such improvement is in most cases temporary. Mletastases in the lungs may be made to disappear, but they usually recur.
Radical surgery, i.e., amputation, remains the only really hopeful treatment, if it may be called so. It is difficult to present figures on this point, for those given by the various authors discussing the same material, differ considerably. Ewing states that among 377 cases registered as osteogenic sarcoma, only twenty-three cases cured for five years could be accepted as of osteogenic origin and clinical malignancy. Of these, twelve were of malignant bone tumours, and eleven of spindle-celled periosteal tumours. All the cured cases of true bone sarcoma had been treated by amputation, combined in most cases, with radiation, and in some, with toxin therapy. Before amputation is undertaken, the diagnosis must be absolutely certain, and the presence of metastases must be excluded by radiographic examination of the chest and the rest of the skeleton. In doubtful cases the tumour may be explored between two tourniquets, but the decision must be made upon its naked-eye appearance; exploration followed by amputation some days later, is inadmissible. Disarticulation at the proximal joint gives no better results than a high amputation, for death is due to distant metastases and not to recurrence in the amputation stump. Local excision, however, is valueless, and should be reserved for lesions on the borderline of malignancy, such as the skeletal' chondromata. This means that surgery hs.s no place in the treatment of osteogenic sarcomata in the skull, vertebral column, or pelvis.
Summing up, Kolodony considers that immobilization on a splint and radiation for a few months, followed by amputation, constitutes the best treatment in hopeful cases. IModerate prophylactic radiation should be given to the chest throughout. When metastases are present, radiation will afford temporary relief, or amputation may be undertaken to relieve intolerable pain which is unaffected by radiation. In Ewing's tumour, radiation leads to rapid improvement, but the condition recurs and becomes refractory to further exposures. When one bone only is involved, radiation followed by amputation is best.
Myeloma yields readily to radium or X-rays, and surgery is of no value. Recurrence is invariable, but in some cases the patients have survived for ten years.
In giant-cell tumours, curetting, followed by application of pure carbolic acid to the wall of the cavity, remains the prevalent treatment; it is, however, followed by local recurrence in 20% of cases. Radiation is being used to an increasing extent in America, and is said to give satisfactory results; in the weight-bearing bones it has manifest advantages over surgery, which, however, always remains for adoption should radiation fail ( fig. 9 ). Amputation is reserved for cases of repeated recurrence, for tumours the microscopic appearance of which is suspicious, for sepsis following local treatment, and for limbs mechanically unstable after curettage. Finally, in view of the hopelessness of all forms of treatment in declared cases of osteogenic sarcoma, and the striking local effects obtained by radiation therapy, Ewing has suggested that all cases of unexplained bone pain which prove refractory to ordinary measures should be given treatment by X-rays.
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Carpal Semilunar Dislocations and Other Wrist Dislocations
with Associated Nerve Lesions.
By R. WATSON JONES, M Ch.Orth., F.R.C.S. PARALYSIS as a primary complication of fractures and dislocations, where bone and nerve injuries are sustained simultaneously, is, I believe, much less rare than is generally recognized. I impress on all those who work in my fracture clinics the necessity of examining every case of bone injury for a possible nerve complication, and in an unexpectedly large proportion of cases we find incomplete palsies from which, with efficient treatment, the patients may completely recover before the splints are discarded and which might with less careful investigation have passed entirely unobserved.
The majority of such combined lesions are found in the elbow region, where ulnar palsies and, less frequently, median or musculo-spinal palsies, may complicate dislocations of the elbow and supracondylar fractures. It has been established that the delayed ulnar palsy, associated with cubitus valgus in an ununited condylar fracture, is due to lengthening of the course of the nerve and traction round the internal condyle, and I believe that the same aetiological factor always exists in the primary ulnar palsy sustained at the time of a supracondylar fracture or elbow dislocation. Only if it is an outward dislocation, or a supracondylar fracture with outward displacement, does ulnar palsy arise as a primary lesion, and in those dislocations of the elbow in which the presence of a force-producing cubitus valgus
